AT
CDNA icon

Arlington Trust’s CareDx CDNA Stock Holding History

Arlington Trust’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.47M Buy
+22,540
New +$1.02M 0.11% 43

Other funds holding CDNA

Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Henry H. Armstrong Associates
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.12B AUM 9.9% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Syntegra Private Wealth Group
Syntegra Private Wealth Group Chesterfield, Missouri $1.3B AUM 10.88% 1-Year Est. Return
TritonPoint Wealth
TritonPoint Wealth Chevy Chase, Maryland $1.01B AUM 25.82% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Arlington Trust's CDNA Position: Q3 2026 in Review

Arlington Trust opened a new position in CareDx (CDNA) in Q3 2026: 22,540 shares worth $1.47M. The stake represents 0.11% of the portfolio and ranks #43 among its holdings.

22 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Arlington Trust held 22,540 shares of CareDx worth $1.47M as of Q3 2026.
  • CareDx was a new Arlington Trust position in Q3 2026.
  • CareDx made up 0.11% of Arlington Trust's portfolio in Q3 2026, its #43 holding.
  • 22 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.